Direct skeletal fixation of limb prostheses using an intraosseous transcutaneous implant (IPG795)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 17 December 2024
Intravascular lithotripsy for calcified arteries in peripheral arterial disease (IPG780)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 3 January 2024
Cardiovascular disease: risk assessment and reduction, including lipid modification (NG238)Product type:GuidanceProgramme:NICE guidelinePublished: 14 December 2023
Percutaneous deep venous arterialisation for chronic limb-threatening ischaemia (IPG773)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 18 October 2023
Automated ankle brachial pressure index measurement devices to detect peripheral arterial disease in people with leg ulcers (DG52)Product type:GuidanceProgramme:Diagnostics guidancePublished: 24 May 2023
Superficial venous arterialisation for chronic limb threatening ischaemia (IPG736)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 24 August 2022
Peripheral arterial disease: diagnosis and management (CG147)Product type:GuidanceProgramme:Clinical guidelineLast updated: 11 December 2020Published: 8 August 2012
Rivaroxaban for preventing atherothrombotic events in people with coronary or peripheral artery disease (TA607)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 17 October 2019
Angioplasty and stenting to treat peripheral arterial disease causing refractory erectile dysfunction (IPG546)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 24 February 2016
Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis (TA308)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 March 2014
Percutaneous laser atherectomy as an adjunct to balloon angioplasty (with or without stenting) for peripheral arterial disease (IPG433)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 27 November 2012
Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease (TA223)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 May 2011
Carotid artery stent placement for symptomatic extracranial carotid stenosis (IPG389)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 27 April 2011
Endovascular stent-grafting of popliteal aneurysms (IPG390)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 27 April 2011
Percutaneous atherectomy of femoropopliteal arterial lesions with plaque excision devices (IPG380)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 23 February 2011
Cardiovascular disease prevention (PH25)Product type:GuidanceProgramme:Public health guidelinePublished: 22 June 2010
Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin (TA159)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 22 October 2008
Lower limb deep vein valve reconstruction for chronic deep venous incompetence (IPG219)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 23 May 2007
Subfascial endoscopic perforator vein surgery (IPG59)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 27 May 2004
PROPATEN heparin-bonded vascular graft for peripheral arterial disease (MIB42)Product type:AdviceProgramme:Medtech innovation briefingPublished: 13 October 2015
Spiral Flow peripheral vascular graft for treating peripheral arterial disease (MIB34)Product type:AdviceProgramme:Medtech innovation briefingPublished: 21 July 2015
Symptoms of peripheral arterial disease: ramipril (ESUOM45)Product type:AdviceProgramme:Evidence summaryPublished: 30 June 2015
Cardiovascular risk assessment and lipid modification (QS100)Product type:Quality standardLast updated: 24 May 2023Published: 4 September 2015
Cardiovascular risk assessment and lipid modificationStatus:In developmentExpected publication date: 23 July 2025
Semaglutide for treating type 2 diabetes and associated peripheral arterial disease TS ID 11791Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC